The LSD1 Inhibitor Iadademstat (ORY-1001) Targets SOX2-driven Breast Cancer Stem Cells: a Potential Epigenetic Therapy in Luminal-B and HER2-positive Breast Cancer Subtypes
Aging（2020）
Key words
epigenetics,reprogramming,cancer stem cells,breast cancer,patient-derived xenografts
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined